2-(2-METHYLPYRIDIN-4-YL)ETHANAMINE, 95.0%, 1g

(R)-6-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-2-methylheptan-2-ol, 98%, 250mg

5-Bromo-1-(bromomethyl)-2,3-difluorobenzene, 98%, 5g

(4R,4'R)-2,2'-(Cyclopropane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 97%, 100mg

4-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole, 95.0%, 10g

1-isopropyl-1H-pyrazol-3-amine, 97.0%, 5g

3,4-Dimethyl-1-phenylpyrano[2,3-c]pyrazol-6(1H)-one, 98%, 1g

N-(4-Hydroxycyclohexyl)acetamide, 95.0%, 500g

1-Boc-6-Amino-1H-indazole, 95.0%, 5g

Lithium formate monohydrate, 98.0%, 100g

3-(2,4-Dichlorophenyl)-3-oxo-propionic acid ethyl ester, 95.0%, 5g

1,3-Bis[1-(2-hydroxyethyl)-4-piperidyl]propane, 5g

2-Cyanobenzamide, 98.0%, 250mg